Literature DB >> 10286022

Formulary decision making: identifying factors that influence P&T committee drug evaluations.

R Segal, D S Pathak.   

Abstract

This study identifies outcomes related to hospital formulary decision making and estimates the importance of 16 specific types of data to five P & T Committees during the formulary decision making process. The two most important outcomes, according to the Committee members involved in this study, were the effects of the potential formulary addition on the quality of drug treatments available in the hospital followed by its impact on hospital costs. Information about the therapeutic advantage of the potential drug addition, the relative adverse effect profile, and cost information were viewed as especially important. On the other hand, promotional literature provided by pharmaceutical companies and letters of evaluation from respected physicians at hospitals other than their own, were not viewed as important. By understanding the factors involved in hospital formulary decision making, strategies encouraging optimal formulary decisions may be developed.

Mesh:

Year:  1988        PMID: 10286022

Source DB:  PubMed          Journal:  Hosp Formul        ISSN: 0098-6909


  7 in total

1.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.

Authors:  R J Lipsy
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

3.  Health professionals: how do they assess new medicines?

Authors:  Rebecca Cheng; Kirsty Cook; Sarah Dowman; Rebecca Lawn; Jemma Leary; Taryn Quinn; Kim Schroder; Nicola Smith; June Tordoff
Journal:  Pharm World Sci       Date:  2005-06

4.  Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes.

Authors:  Adeline Gallini; Blandine Juillard-Condat; Marie-Claude Saux; Florence Taboulet
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

5.  [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].

Authors:  S Harder; P Thürmann; A Steioff
Journal:  Med Klin (Munich)       Date:  1998-02-15

6.  P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.

Authors:  Laila Carolina Abu Esba; Hind Almodaimegh; Ali Alhammad; Mazen Ferwana; Consuela Yousef; Sherine Ismail
Journal:  P T       Date:  2018-05

7.  Selection of medicines in Chilean public hospitals: an exploratory study.

Authors:  Juan F Collao; Felicity Smith; Nick Barber
Journal:  BMC Health Serv Res       Date:  2013-01-07       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.